Dual PI3K/mTOR Inhibitor NVP-BEZ235 Sensitizes Docetaxel in Castration Resistant Prostate Cancer
Keywords: prostate; prostatic neoplasms; drug resistance; docetaxel; dactolisibCRPC, castration resistant prostate cancer; MAPK, mitogen-activated protein kinase; mTOR, mammalian target of rapamycin; mTORC, mTOR complex; p, phosphorylated; PBS, phosphate buffered s